A detailed history of Bridgeway Capital Management, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 95,143 shares of KMPH stock, worth $470,006. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95,143
Previous 95,143 -0.0%
Holding current value
$470,006
Previous $470,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$4.13 - $6.27 $23,541 - $35,739
5,700 Added 6.37%
95,143 $523,000
Q4 2022

Feb 14, 2023

BUY
$4.12 - $5.62 $84,460 - $115,210
20,500 Added 29.73%
89,443 $410,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $5.21 $277,150 - $359,193
68,943 New
68,943 $307,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.